Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) Income from Continuing Operations (2016 - 2025)

United Health Products (UEEC) has disclosed Income from Continuing Operations for 15 consecutive years, with 263863.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 33.95% to 263863.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 2806833.0, a 68.33% decrease, with the full-year FY2024 number at 2007572.0, up 17.54% from a year prior.
  • Income from Continuing Operations was 263863.0 for Q3 2025 at United Health Products, up from 268356.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 263863.0 in Q3 2025 to a low of 27094995.0 in Q1 2021.
  • A 5-year average of 2069644.53 and a median of 562110.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: plummeted 4243.5% in 2021, then soared 96.48% in 2022.
  • United Health Products' Income from Continuing Operations stood at 907300.0 in 2021, then surged by 38.05% to 562110.0 in 2022, then rose by 24.85% to 422409.0 in 2023, then crashed by 85.93% to 785398.0 in 2024, then skyrocketed by 66.4% to 263863.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Income from Continuing Operations are 263863.0 (Q3 2025), 268356.0 (Q2 2025), and 1489216.0 (Q1 2025).